SKT and SK Biopharmaceuticals shorten early-stage research period for new drugs for intractable cancer by 60% using AI

SKT and SK Biopharm have discovered two initial active substances for cancer-targeted therapeutics through joint AI research based on machine learning…

2026.07.15 by 명세환 기자